JCM
BBC icon

Jacobi Capital Management’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Jacobi Capital Management’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-20
Closed -$1K – 499
2021
Q3 		$1K Buy
+20
New +$935 ﹤0.01% 1362

Other funds holding BBC

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Jacobi Capital Management's BBC Position: Q4 2021 in Review

Jacobi Capital Management sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q4 2021, closing a stake of 20 shares — an estimated $1K sold.

Jacobi Capital Management first reported a position in BBC in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 19 funds tracked by Wall St. Rank hold BBC as of Q4 2021.

  • Jacobi Capital Management reported no remaining Virtus Biotech Clinical Trials ETF position as of Q4 2021 after selling out during the quarter.
  • Jacobi Capital Management sold 20 Virtus Biotech Clinical Trials ETF shares in Q4 2021, an estimated $1K.
  • Jacobi Capital Management first reported a position in Virtus Biotech Clinical Trials ETF in Q3 2021 and held it in 1 quarter.
  • Jacobi Capital Management's Virtus Biotech Clinical Trials ETF position peaked at $1K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.